Polatuzumab vedotin intravenous infusion used to treat certain types of lymphoma
Contains polatuzumab vedotin 140 mg, an antibody-drug conjugate that targets and destroys cancerous B-cells, used with other medicines to treat relapsed or refractory diffuse large B-cell lymphoma.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by intravenous infusion in a hospital setting.
• Dose and schedule are decided by your oncologist.
• Regular blood tests are needed; report signs of infection or numbness.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Polivy 140mg 1 Vial (Refregirated) has been copied